Skip to main content

Table 3 Indeterminate vs evaluable by lymphoma diagnosis

From: Kappa and lambda light chain mRNA in situ hybridization compared to flow cytometry and immunohistochemistry in B cell lymphomas

Diagnosis

Cases

Indeterminate

Evaluable

Follicular

34

6/34 (17.6%)

28/34 (82.4%)

Mantle cell

7

0/7 (0%)

7/7 (100%)

Marginal Zone

11

1/11 (9%)

10/11 (91%)

Lymphoplasmacytic

6

0/6 (0%)

6/6 (100%)

Diffuse Large B Cell

15

2/15 (13.3%)

13/15 (86.7%)

CLL/SLL

4

0/4 (0%)

4/4 (100%)

Small B Cell NHL, NOS

2

0/2 (0%)

2/2 (100%)

Total

79

9/79 (11.3%)

70/79 (88.6%)